XML 52 R45.htm IDEA: XBRL DOCUMENT v3.26.1

Share Capital (Tables)

3 Months Ended

Jun. 30, 2026

Equity [Abstract]

Summary of Other Issuances and Share Capital Transactions

During the three months ended June 30, 2026, the Company had the following other issuances and share capital transactions:

		Number of common shares				Share capital				Share and warrant reserve
Other issuances and share issue costs			-			$	(571	)		$	-
Total			-			$	(571	)		$	-

During the three months ended June 30, 2025, the Company had the following other issuances and share capital transactions:

		Number of common shares				Share capital				Share based reserve
Other issuances and share issue costs			-			$	(1,585	)		$	-
Total			-			$	(1,585	)		$	-

Summary of Warrants

The following is a summary of the Company’s liability classified warrant activity during the three months ended June 30, 2026 and 2025:

		Number of whole warrants				Weighted average exercise price				Weighted average remaining life (years)
Balance outstanding at March 31, 2026			30,838,728			$	4.49				4.11
Issuance of warrants			-				-				-
Balance outstanding at June 30, 2026			30,838,728			$	4.58				3.87

		Number of whole warrants				Weighted average exercise price				Weighted average remaining life (years)
Balance outstanding at March 31, 2025			12,133,150			$	8.90				4.09
Issuance of warrants			-				-				-
Balance outstanding at June 30, 2025			12,133,150			$	8.41				3.84

The following is a summary of the Company’s liability classified warrant balances during the three months ended June 30, 2026 and 2025:

		Warrant derivative liability
Balance outstanding at March 31, 2026		$	27,522
Fair value change			(659	)
Balance outstanding at June 30, 2026		$	26,863

		Warrant derivative liability
Balance outstanding at March 31, 2025		$	8,647
Fair value change			3,334
Balance outstanding at June 30, 2025		$	11,981

(iv) Equity classified warrants

The following is a summary of the Company’s equity classified warrant activity during the three months ended June 30, 2026 and 2025:

		Number of whole warrants				Weighted average exercise price				Weighted average remaining life (years)				Warrant reserve
Balance outstanding at March 31, 2026			23,528,830			$	4.08				3.46			$	2,612,631
Issuance of warrants			-				-				-				-
Balance outstanding at June 30, 2026			23,528,830			$	4.08				3.21			$	2,612,631

		Number of whole warrants				Weighted average exercise price				Weighted average remaining life (years)				Warrant reserve
Balance outstanding at March 31, 2025			3,350,430			$	16.18				4.12			$	2,590,485
Issuance of warrants			-				-				-				-
Balance outstanding at June 30, 2025			3,350,430			$	16.18				3.87			$	2,590,485

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of equity interest issued or issuable by acquirer as part of consideration transferred in business combination.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-2

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-1

+ Details

Name:	us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration